Therefore, MT1 proteins can serve as biomarkers of HCC, and these findings may lead to the development of new and effective therapeutic modalities if the mechanism and function of MT1 proteins in the development of HCC can be elucidated. The gene discussed is MT1H; the disease is hepatocellular carcinoma.